Table 1.
Patients and tumour characteristics
| Upper Third | Middle Third | Lower Third | Total | |
|---|---|---|---|---|
| n=23 (19.5%) | n=65 (55.1%) | n=30 (25.4%) | n=118 | |
| Mean age (years) | 48.4±11.5 | 48.8±15.6 | 44.3±15.1 | 47.5±14.7 |
| Range (years) | 26-66 | 19-86 | 17-75 | 17-86 |
| Sex ratio (m/f) | 4/19 | 13/52 | 8/22 | 25/93 |
| Stage I | 9 (39.1%) | 31 (47.7%) | 18 (60.0%) | 58 (49.2%) |
| Stage II | 1 (4.4%) | 2 (3.1%) | 2 (6.7%) | 5 (4.2%) |
| Stage III | 13 (56.5%) | 27 (41.5%) | 8 (26.6%) | 48 (40.7%) |
| Stage IV | - | 5 (7.7%) | 2 (6.7%) | 7 (5.9%) |
| T1 | 10 (43.5%) | 24 (36.9%) | 20 (66.7%) | 54 (45.8%) |
| T2 | 3 (13.0%) | 9 (13.9%) | 6 (20.0%) | 18 (15.3%) |
| T3 | 10 (43.5%) | 29 (44.6%) | 4 (13.3%) | 43 (36.4%) |
| T4 | - | 3 (4.6%) | - | 3 (2.5%) |
| Size (mm) | 13.9±7.9 | 20.6±14.3 | 13.8±7.1 | 17.6±12.1 |
| Range (mm) | 5-40 | 1-65 | 4-35 | 1-65 |
| Multifocality (%) | 9 (39.1%) | 16 (24.6%) | 12 (40.0%) | 37 (31.3%) |